Title: Medical Education Lead Rare Diseases
Company: Ipsen Biopharm Ltd
About Ipsen:
Ipsen is a mid-sized global biopharmaceutical company with a focus on transformative medicines in three therapeutic areas: Oncology, Rare Disease and Neuroscience. Supported by nearly 100 years of development experience, with global hubs in the U.S., France and the U.K, we tackle areas of high unmet medical need through research and innovation.
Our passionate teams in more than 40 countries are focused on what matters and endeavor every day to bring medicines to patients in 88 countries. We build a workplace that champions human-centric leadership and fosters a culture of collaboration, excellence and impact. At Ipsen, every individual is empowered to be their true selves, grow and thrive alongside the company's success. Join us on our journey towards sustainable growth, creating real impact on patients and society!
For more information, visit us at and follow our latest news on and .
:
Job Advertisement
Ipsen is a dynamic and growing global specialty-driven biopharmaceutical company focused on innovation and specialty care.
We aim to make a sustainable difference by significantly improving patients' health and quality of life and providing them with effective therapeutic solutions for unmet medical needs through differentiated and innovative medicines in Oncology, Neurosciences and Rare Diseases.
The patient is at the heart of everything we do, and we also care for our employees because they are the ambassadors who truly make the difference. We attract and develop bold, agile, entrepreneurial individuals who take full ownership of their decisions; leaders drawn by a purpose to make a direct impact through their work in people's lives.
We offer employees a wealth of fulfilling challenges & growth opportunities, and the chance to contribute within a fast-moving organisation, an organisation that is genuinely game-changing.
As Medical Education Lead Rare Diseases, you will focus on developing external medical education strategies for the prioritised Rare Diseases launch brands/assets from -2 years to +2 years from launch.
The strategy will be defined from needs analysis of all focus stakeholder groups, and will aim to deliver tangible impact on clinical management aligned to guidelines as well as positively impacting on care gaps. It will include analysis of the channels of preference and to ensure appropriate and multi channel solutions are developed with an educational continuum to achieve optimal impact.
Main Responsibilities:
MNCJobs.co.uk will not be responsible for any payment made to a third-party. All Terms of Use are applicable.